Hippocalcin-Like 1 blunts liver lipid metabolism to suppress tumorigenesis via directly targeting RUVBL1-mTOR signaling

Rationale: Hepatocellular carcinoma (HCC) is one of the most severe cancers worldwide, with few effective targeted therapies for HCC. Lipid metabolic reprogramming is emerged as a hallmark of cancer metabolism that guides response to antitumoral therapies. Such lipid metabolic alteration in cancers...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tao, Yuan, Zhiqing, Lei, Zhou, Duan, Jinlin, Xue, Junyan, Lu, Ting, Yan, Guouan, Zhang, Lei, Liu, Yanfeng, Li, Qiwei, Zhang, Yonglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691343/
https://www.ncbi.nlm.nih.gov/pubmed/36438486
http://dx.doi.org/10.7150/thno.75936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691343/
https://www.ncbi.nlm.nih.gov/pubmed/36438486
http://dx.doi.org/10.7150/thno.75936

Ejemplares similares